Coronary revascularization and aggressive lipid lowering.
Pershad
A
A
Cardiology Fellow, Department of Cardiology, Carl T. Hayden VA Medical Center, 650 E. Indian School Road, Phoenix, AZ 85012, USA.
Kratzer
S
S
Cooper
A
A
D001241:Aspirin / Q000627:therapeutic use; D000069059:Atorvastatin; D023921:Coronary Stenosis / Q000188:drug therapy*; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use; D008875:Middle Aged; D009204:Myocardial Revascularization; D010960:Plasminogen Activators / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use; D012307:Risk Factors
D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D011758:Pyrroles; D000069059:Atorvastatin; D010960:Plasminogen Activators; D008790:Metoprolol; D001241:Aspirin